Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.

作者: Xiao Ni , Heather M. Richmond , Xingsheng M. Liao , William K. Decker , Lisa H. Shiue

DOI: 10.1038/JID.2008.125

关键词:

摘要: Sezary syndrome (SzS), the leukemic variant of cutaneous T-cell lymphomas, is incurable. Dendritic cells (DCs) transfected with tumor mRNA can stimulate antitumor immunity in certain cancer patients. In this study, we determined whether mRNAs from could be used for loading DCs and stimulating immunity. Autologous were generated monocytes peripheral blood 10 patients SzS. Total RNA was extracted amplified by T7 vitro transcription. The induction IFN-γ granzyme B (GrB)-producing cytotoxic T lymphocytes (CTL) RNA-transfected ELISPOT assays. We found that required IL-12p70 production monocyte-derived oncogenic transcription factor Twist tyrosine kinase receptor EphA4 expressed total paired mRNAs. induced IFN-γ-producing CTLs 7 subjects GrB-producing 6 9 subjects. Both CD3+CD8+ CD4+CD25+ expanded without regulatory cells. These data support concept using a vaccine strategy requires small amounts need specific antigens

参考文章(36)
G. Crovetti, A. Carabelli, E. Berti, M. Guizzardi, S. Fossati, C. De Filippo, E. Bertani, Photopheresis in Cutaneous T-cell Lymphoma: Five-Year Experience International Journal of Artificial Organs. ,vol. 23, pp. 55- 62 ,(2000) , 10.1177/039139880002300109
B. R. Vowels, A. H. Rook, S. R. Lessin, M. Kubin, Anjali Singh, M. Cassin, S. F. Wolf, J. T. Wolfe, G. Trinchieri, E. C. Vonderheid, IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. Journal of Immunology. ,vol. 154, pp. 1491- 1498 ,(1995)
Silvija Jarnjak-Jankovic, Rolf D Pettersen, Stein Sæbøe-Larssen, Finn Wesenberg, Gustav Gaudernack, Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia BMC Cancer. ,vol. 5, pp. 20- 20 ,(2005) , 10.1186/1471-2407-5-20
Anatoli Malyguine, Susan Strobl, Liubov Zaritskaya, Michael Baseler, Kimberly Shafer-Weaver, New Approaches for Monitoring CTL Activity in Clinical Trials Advances in Experimental Medicine and Biology. ,vol. 601, pp. 273- 284 ,(2007) , 10.1007/978-0-387-72005-0_29
E Gilboa, D Boczkowski, S K Nair, H K Lyerly, J H Nam, Induction of Tumor Immunity and Cytotoxic T Lymphocyte Responses Using Dendritic Cells Transfected with Messenger RNA Amplified from Tumor Cells Cancer Research. ,vol. 60, pp. 1028- 1034 ,(2000)
Madeleine Duvic, Timothy M. Kuzel, Elise A. Olsen, Ann G. Martin, Francine M. Foss, Youn H. Kim, Peter W. Heald, Patricia Bacha, Jean Nichols, Astra Liepa, Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK®) Clinical Lymphoma, Myeloma & Leukemia. ,vol. 2, pp. 222- 228 ,(2002) , 10.3816/CLM.2002.N.003
A. Karolina Palucka, Hideki Ueno, Joseph W. Fay, Jacques Banchereau, Taming cancer by inducing immunity via dendritic cells Immunological Reviews. ,vol. 220, pp. 129- 150 ,(2007) , 10.1111/J.1600-065X.2007.00575.X
Maria Wysocka, Mohamed H. Zaki, Lars E. French, Jihed Chehimi, Michael Shapiro, Suzanne E. Everetts, Karen S. McGinnis, Luis Montaner, Alain H. Rook, Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines Blood. ,vol. 100, pp. 3287- 3294 ,(2002) , 10.1182/BLOOD-2002-01-0231
John A. Zic, The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatologic Therapy. ,vol. 16, pp. 337- 346 ,(2003) , 10.1111/J.1396-0296.2003.01646.X